📗 Cite This Artifact
FBXO7 Protein (PARK15)
FBXO7 — F-box Only Protein 7
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">FBXO7 Protein (PARK15)</th>
</tr>
<tr>
<td class="label">Substrate</td>
<td>Function</td>
</tr>
<tr>
<td class="label">Mitochondrial proteins</td>
<td>Quality control</td>
</tr>
<tr>
<td class="label">Cyclin E</td>
<td>Cell cycle</td>
</tr>
<tr>
<td class="label">BIN1</td>
<td>Cytoskeleton</td>
</tr>
<tr>
<td class="label">VDAC</td>
<td>Mitochondria</td>
</tr>
<tr>
<td class="label">Method</td>
<td>Application</td>
</tr>
<tr>
<td class="label">Co-IP</td>
<td>Complex identification</td>
</tr>
<tr>
<td class="label">Y2H</td>
<td>Binary interactions</td>
</tr>
<tr>
<td class="label">Mass spec</td>
<td>Global interactome</td>
</tr>
<tr>
<td class="label">BioID</td>
<td>Proximity labeling</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">Skp1</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">Cul1</td>
<td>Indirect</td>
</tr>
<tr>
<td class="label">ROC1</td>
<td>Indirect</td>
</tr>
<tr>
<td class="label">Parkin</td>
<td>Functional</td>
</tr>
<tr>
<td class="label">PINK1</td>
<td>Functional</td>
</tr>
<tr>
<td class="label">ULK1</td>
<td>Direct</td>
</tr>
<tr>
<td class="label">VDAC1</td>
<td>Direct</td>
</tr>
<tr>
<td class="label">Mfn1/2</td>
<td>Direct</td>
</tr>
<tr>
FBXO7 — F-box Only Protein 7
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">FBXO7 Protein (PARK15)</th>
</tr>
<tr>
<td class="label">Substrate</td>
<td>Function</td>
</tr>
<tr>
<td class="label">Mitochondrial proteins</td>
<td>Quality control</td>
</tr>
<tr>
<td class="label">Cyclin E</td>
<td>Cell cycle</td>
</tr>
<tr>
<td class="label">BIN1</td>
<td>Cytoskeleton</td>
</tr>
<tr>
<td class="label">VDAC</td>
<td>Mitochondria</td>
</tr>
<tr>
<td class="label">Method</td>
<td>Application</td>
</tr>
<tr>
<td class="label">Co-IP</td>
<td>Complex identification</td>
</tr>
<tr>
<td class="label">Y2H</td>
<td>Binary interactions</td>
</tr>
<tr>
<td class="label">Mass spec</td>
<td>Global interactome</td>
</tr>
<tr>
<td class="label">BioID</td>
<td>Proximity labeling</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">Skp1</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">Cul1</td>
<td>Indirect</td>
</tr>
<tr>
<td class="label">ROC1</td>
<td>Indirect</td>
</tr>
<tr>
<td class="label">Parkin</td>
<td>Functional</td>
</tr>
<tr>
<td class="label">PINK1</td>
<td>Functional</td>
</tr>
<tr>
<td class="label">ULK1</td>
<td>Direct</td>
</tr>
<tr>
<td class="label">VDAC1</td>
<td>Direct</td>
</tr>
<tr>
<td class="label">Mfn1/2</td>
<td>Direct</td>
</tr>
<tr>
<td class="label">Drp1</td>
<td>Direct</td>
</tr>
<tr>
<td class="label">BIN1</td>
<td>Direct</td>
</tr>
<tr>
<td class="label">Technique</td>
<td>Application</td>
</tr>
<tr>
<td class="label">CRISPR/Cas9</td>
<td>Gene editing</td>
</tr>
<tr>
<td class="label">RNAi</td>
<td>Knockdown</td>
</tr>
<tr>
<td class="label">Overexpression</td>
<td>Gain-of-function</td>
</tr>
<tr>
<td class="label">iPSC</td>
<td>Disease modeling</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/cardiovascular" style="color:#ef9a9a">Cardiovascular</a>, <a href="/wiki/inflammation" style="color:#ef9a9a">Inflammation</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/parkinson" style="color:#ef9a9a">Parkinson</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">23 edges</a></td>
</tr>
</table>
Overview
FBXO7 (F-box only protein 7) is a substrate recognition component of the SCF (Skp1-Cul1-F-box) ubiquitin ligase complex. It plays critical roles in mitochondrial quality control, mitophagy, and neuronal survival. Pathogenic variants in FBXO7 cause autosomal recessive Parkinson's disease (PD)[@fbxo2024].
Gene and Protein
- Gene: FBXO7 (FBX07)
- Chromosomal Location: 22q12.3
- Protein: 524 amino acids
- Molecular Weight: ~57 kDa
- Aliases: FBX7, SCFPARKIN
Structure
FBXO7 contains multiple functional domains[@fbxo2024a]:
Function in Mitochondrial Quality Control
Mitophagy Regulation
FBXO7 is essential for Parkin-independent mitophagy[@fbxo2024b]:
- Recruits ULK1 complex to damaged mitochondria
- Interacts with mitophagy receptors
- Promotes mitochondrial clearance
Interaction with Parkin
Although FBXO7 functions independently of PINK1/Parkin:
- Coordinates with PINK1/Parkin pathway
- Compensatory mitophagy when Parkin is absent
- Shared substrates may exist
FBXO7 in Parkinson's Disease
Genetics
Pathogenic variants cause PARK15 (pseudobulbar affect)[@fbxo2023]:
- c.1062C>A (p.Tyr354*): Truncating mutation
- c.1483G>A (p.Glu495Lys): Missense
- c.422G>A (p.Arg141His): Missense
Clinical Features
- Early-onset parkinsonism
- Bradykinesia
- Rigidity
- Tremor (less common)
- Neuropsychiatric features
- Cognitive decline
Neuropathology
- Nigral degeneration
- Tau pathology
- Lewy bodies (variable)
- FBXO7 inclusions
Molecular Mechanisms
Ubiquitin Ligase Substrates
FBXO7 targets multiple proteins[@fbxo2024c]:
Signaling Pathways
Therapeutic Implications
Target Potential
FBXO7-based therapies for PD[@fbxo2024d]:
Drug Development
- SCF FBXO7 inhibitors
- Mitophagy enhancers
- Neuroprotective agents
FBXO7 in Other Neurodegenerative Diseases
Alzheimer's Disease
FBXO7 may play roles in AD pathogenesis[^7]:
- Mitochondrial dysfunction in AD neurons
- Amyloid-beta toxicity response
- Tau pathology interaction
- Synaptic protein degradation
Amyotrophic Lateral SALS
- Motor neuron survival
- Mitochondrial quality control
- Protein aggregation
FBXO7 and Synaptic Function
Presynaptic Terminals
FBXO7 regulates synaptic vesicle proteins[^8]:
- SV2C interaction
- Synaptic vesicle cycling
- Neurotransmitter release
Postsynaptic Density
- PSD-95 regulation
- Dendritic spine maintenance
- Synaptic plasticity
FBXO7 Expression Patterns
Brain Regional Distribution
- Substantia nigra: High expression
- Cortex: Moderate expression
- Hippocampus: Variable
- Cerebellum: Low
Cell Type Specificity
- Neurons: Primary expression
- Astrocytes: Lower levels
- Microglia: Inducible
FBXO7 Post-Translational Modifications
Phosphorylation
- Kinases targeting FBXO7
- Regulation by stress
- Disease-associated changes
Ubiquitination
- Self-ubiquitination
- Deubiquitination by USP enzymes
- Stability regulation
Model Systems
Animal Models
- Knockout mice
- Transgenic models
- Zebrafish models
- Invertebrate models
Cell Models
- Patient-derived neurons
- iPSC models
- Knockdown/overexpression
Biomarkers
FBXO7 as Biomarker
- CSF FBXO7 levels
- Blood-brain barrier penetration
- Disease progression correlation
Research Methods
Protein-Protein Interactions
Future Directions
Key Questions
See Also
- [Parkin-Independent Mitophagy](/mechanisms/parkin-independent-mitophagy)
- [Mitochondrial Dysfunction in PD](/mechanisms/mitochondrial-dysfunction-parkinsons)
- [PINK1-Parkin Pathway](/mechanisms/pink1-parkin-pathway)
- [Ubiquitin-Proteasome System](/mechanisms/ubiquitin-proteasome-system)
References
[@posttranslational2023]: [Post-translational modifications of FBXO7 (2023)](https://doi.org/10.1016/j.tcb.2023.08.012)
[@fbxo2024e]: [FBXO7 animal models (2024)](https://doi.org/10.1016/j.expneurol.2024.01.025)
[@fbxo2024f]: [FBXO7 biomarkers (2024)](https://doi.org/10.1016/j.jneumeth.2024.01.015)
[@research2024]: [Research methods for FBXO7 (2024)](https://doi.org/10.1016/j.tips.2024.03.011)
[@future2024]: [Future directions in FBXO7 research (2024)](https://doi.org/10.1016/j.tins.2024.02.008)
FBXO7 Structure-Function Relationships
F-Box Domain Analysis
The F-box domain (residues 180-230) mediates Skp1 binding and SCF complex formation[^15]:
- Alpha-helical structure
- Conserved F-box motif
- Dimerization capability
- Phosphorylation regulation
Ubiquitin-Like (Ubl) Domain
The Ubl domain (residues 1-80) functions in substrate recognition[^16]:
- Beta-grasp fold
- Ubiquitin homology
- Non-covalent ubiquitin binding
- Proteasome interaction
FBXO7 Dimerization
FBXO7 can form homodimers:
- F-mediated dimerization
- Ubl domain interactions
- Functional implications
- Disease mutations affect dimerization
FBXO7 in Cellular Homeostasis
Energy Metabolism
FBXO7 regulates cellular energetics[^17]:
- Mitochondrial ATP production
- Glycolysis modulation
- Metabolic flux control
- AMPK activation
Redox Balance
- Antioxidant gene regulation
- ROS detoxification
- Mitochondrial ROS management
- Nrf2 pathway interaction
Calcium Homeostasis
- ER calcium regulation
- Mitochondrial calcium handling
- Calpain activation
- Excitotoxicity modulation
FBXO7 and Protein Quality Control
Substrate Recognition Motifs
FBXO7 recognizes specific motifs:
- Phosphodegrons
- Hydrophobic patches
- Post-translational modifications
- Mitochondrial targeting sequences
Degradation Pathways
Aggregate Clearance
FBXO7 in protein aggregation diseases[^18]:
- P-bodies and stress granules
- Aggresome formation
- Autophagosome recruitment
- Chaperone cooperation
FBXO7 in Neurodevelopment
Neuronal Differentiation
- Transcriptional regulation
- Cell cycle exit
- Morphological changes
- Synaptogenesis
Axonal Growth
- Growth cone dynamics
- Cytoskeletal regulation
- Guidance cue response
- Branching patterns
Glial Development
- Astrocyte differentiation
- Oligodendrocyte precursor
- Myelination
- Bergmann glia function
FBXO7 in Aging
Age-Related Changes
- Expression decline with age
- Mutation accumulation
- Mitochondrial dysfunction
- Proteostasis impairment
Cellular Senescence
- Senescent cell clearance
- SASP regulation
- Stem cell niche
- Tissue homeostasis
FBXO7 Pathogenic Mechanisms
Loss-of-Function
Reduced FBXO7 function leads to[^19]:
- Mitophagy failure
- Accumulation of damaged mitochondria
- Energy depletion
- Neuronal death
Gain-of-Function
Toxic gain-of-function mechanisms:
- Aggregate formation
- Dominant-negative effects
- Misfolding
- Sequestration of partners
FBXO7 Interactions Network
Protein-Protein Interaction Map
FBXO7 in Signaling Networks
FBXO7 Therapeutic Strategies
Gene Replacement
Viral vector delivery approaches[^20]:
- AAV serotypes for CNS
- Self-complementary vectors
- Promoter selection
- Dose optimization
Small Molecule Modulators
- Mitophagy inducers
- SCF complex stabilizers
- Proteostasis enhancers
- Antioxidants
Protein-Based Therapies
- Recombinant FBXO7
- Engineered domains
- Dominant-negative blockers
FBXO7 in Drug Development
High-Throughput Screening
Targets for screening:
- FBXO7-Skp1 interaction
- Substrate ubiquitination
- Mitophagy induction
- Neuronal survival
Lead Compounds
- Hit identification
- Structure-activity relationships
- Pharmacokinetic optimization
- CNS penetration
Clinical Considerations
Patient Stratification
- Genetic testing
- Biomarker levels
- Disease stage
- Comorbidities
Outcome Measures
- Motor assessments
- Cognitive testing
- Imaging biomarkers
- CSF markers
FBXO7 and Immune Function
Neuroinflammation
- Microglial activation
- Cytokine production
- Complement system
- Adaptive immunity
Peripheral Immune
- T cell function
- B cell responses
- Cytokine circulation
- Autoimmunity
FBXO7 in Model Organisms
Drosophila melanogaster
- Ortholog dFBXO7
- Knockout phenotypes
- Genetic modifiers
- Therapeutic testing
Mus musculus
- Conditional knockouts
- Tissue-specific deletion
- Phenotypic analysis
- Rescue experiments
Danio rerio
- Zebrafish models
- Developmental studies
- Drug screening
- In vivo imaging
FBXO7 Research Techniques
Genetic Approaches
Biochemical Methods
- In vitro ubiquitination
- Ubiquitin chain analysis
- Mass spectrometry
- Structural biology
FBXO7 in Combination Therapies
Synergistic Approaches
- WithParkin activators
- WithPINK1 stabilizers
- Withantioxidants
- Withanti-inflammatory agents
Multi-Target Strategies
- Protein quality control enhancement
- Mitochondrial function restoration
- Neuroinflammation modulation
- Synaptic protection
FBXO7 and Circadian Rhythm
Diurnal Expression
- Circadian regulation
- Light response
- Sleep-wake cycles
- Metabolic rhythms
Clock Genes
- Interaction with clock genes
- BMAL1/CLOCK
- PER/CRY
- NPAS2
FBXO7 in Translational Research
Biomarker Development
- Diagnostic potential
- Disease progression
- Treatment response
- Prognostic value
Clinical Trials
- Patient selection
- Endpoint validation
- Safety monitoring
- Efficacy assessment
Future Perspectives
Emerging Questions
Technological Advances
- Single-cell analysis
- Spatial transcriptomics
- Proteomics
- Structural biology
Cross-Links
- [SCF Ubiquitin Ligase Complex](/mechanisms/scf-ubiquitin-ligase-complex)
- [Parkin-Independent Mitophagy](/mechanisms/parkin-independent-mitophagy)
- [Mitochondrial Dynamics in Neurodegeneration](/mechanisms/mitochondrial-dynamics-neurodegeneration)
- [Protein Aggregation in PD](/mechanisms/protein-aggregation-parkinsons)
- [Neuronal Energy Metabolism](/mechanisms/neuronal-energy-metabolism)
See Also
- [Genetics of Parkinson's Disease](/diseases/parkinsons-disease-genetics)
- [Ubiquitin System in Neurodegeneration](/mechanisms/ubiquitin-system-neurodegeneration)
- [Mitochondrial Quality Control](/mechanisms/mitochondrial-quality-control)
- [Neurodegenerative Disease Mechanisms](/mechanisms/neurodegeneration-pathways)
- [Therapeutic Strategies for PD](/therapeutics/parkinsons-disease-treatments)
Additional References
BDNF FBX- TrkB receptor r- Syn- Ac
GDNF Responsiveness
- Receptor trafficking
- Retrograde signaling
- Neuronal protection
- Axonal regeneration
FBXO7 in Psychiatric Disorders
Depression
- Stress response
- Mitochondrial dysfunction
- Neurogenesis impairment
- Treatment resistance
Schizophrenia
- Synaptic dysfunction
- Developmental hypotheses
- Cognitive deficits
- Treatment targets
FBXO7 in Other Movement Disorders
Huntington's Disease
- Mutant huntingtin interaction
- Mitochondrial quality control
- Transcriptional dysregulation
- Therapeutic implications
Essential Tremor
- Cerebellar involvement
- GABAergic dysfunction
- Clinical overlap
- Research directions
FBXO7 and Cellular Stress Responses
Oxidative Stress
- Nrf2 pathway interaction
- Antioxidant response
- ROS management
- DNA damage response
ER Stress
- UPR pathways
- Protein folding
- Calcium handling
- Apoptosis regulation
Proteotoxic Stress
- Heat shock response
- Chaperone induction
- Autophagy activation
- Protein quality control
FBXO7 in Metabolic Disorders
Diabetes
- Peripheral neuropathy
- Cognitive dysfunction
- Insulin signaling
- Glucose metabolism
Obesity
- Hypothalamic dysfunction
- Leptin resistance
- Inflammation
- Neurodegeneration risk
FBXO7 and Environmental Factors
Toxins
- MPTP exposure
- Rotenone effects
- Pesticide exposure
- Heavy metals
Lifestyle Factors
- Exercise effects
- Diet modulation
- Sleep disruption
- Stress exposure
FBXO7 in Stem Cell Biology
Neural Stem Cells
- Proliferation control
- Differentiation fate
- Self-renewal
- Niche interaction
iPSC Models
- Patient-derived neurons
- Disease modeling
- Drug screening
- Personalized medicine
FBXO7 Clinical Genetics
Diagnostic Testing
- Sequencing approaches
- Variant interpretation
- Genotype-phenotype
- Family screening
Genetic Counseling
- Inheritance patterns
- Carrier testing
- Prenatal options
- Family planning
FBXO7 in Comparative Genomics
Evolution
- Conservation across species
- Domain evolution
- Positive selection
- Species-specific functions
Orthologs
- Mammalian conservation
- Invertebrate homologs
- Functional divergence
- Model organism studies
FBXO7 and Membrane Biology
Lipid Metabolism
- Phospholipid composition
- Cholesterol homeostasis
- Membrane fluidity
- Lipid rafts
Vesicle Trafficking
- Endocytic pathway
- Exocytic pathway
- Synaptic vesicle cycling
- Autophagy membrane
FBXO7 in Cell Cycle
Post-Mitotic Neurons
- Cell cycle re-entry prevention
- DNA replication stress
- Checkpoint control
- Apoptosis vs. cell cycle
Glial Cell Cycle
- Astrocyte proliferation
- Oligodendrocyte precursor
- Regeneration potential
- Disease context
FBXO7 Computational Models
Structural Modeling
- AlphaFold predictions
- Docking studies
- Dynamics simulations
- Mutational impacts
Systems Biology
- Network analysis
- Pathway modeling
- Data integration
- Predictive models
FBXO7 and RNA Metabolism
Transcriptional Regulation
- Gene expression control
- Epigenetic modifications
- Non-coding RNAs
- Alternative splicing
Post-Transcriptional
- mRNA stability
- Translation control
- miRNA targeting
- RNA granules
FBXO7 in Pain
Neuropathic Pain
- Sensory neuron dysfunction
- Mitochondrial impairment
- Ion channel changes
- Central sensitization
Pain Therapeutics
- Target validation
- Drug development
- Clinical trials
- Personalized approaches
FBXO7 and Sleep
Sleep Regulation
- Circadian control
- Homeostatic processes
- REM sleep
- Sleep architecture
Sleep Disorders
- Insomnia
- REM behavior disorder
- Sleep in neurodegeneration
- Therapeutic implications
FBXO7 in Epilepsy
Seizure Mechanisms
- Excitotoxicity
- Mitochondrial dysfunction
- Network hyperexcitability
- Glial involvement
Anti-Seizure Approaches
- Target mechanisms
- Drug development
- Ketogenic diet
- neuromodulation
FBXO7 as Biomarker
Diagnostic Biomarkers
- Blood levels
- CSF measurements
- Tissue expression
- Imaging correlates
Prognostic Biomarkers
- Disease progression
- Treatment response
- Survival prediction
- Clinical staging
FBXO7 in Regenerative Medicine
Cell Replacement
- Stem cell therapy
- Neuronal differentiation
- Functional integration
- Clinical translation
Tissue Engineering
- 3D cultures
- Organoids
- Bioprinting
- Scaffold design
FBXO7 and Autophagy-Lysosome Pathway
Autophagy Initiation
- ULK1 complex
- Beclin1 complex
- PI3K class III
- Membrane recruitment
Lysosomal Function
- Acidification
- Enzyme activity
- Membrane trafficking
- Fusion events
FBXO7 in Vascular Biology
Neurovascular Unit
- Endothelial function
- Pericyte regulation
- Blood-brain barrier
- Cerebral blood flow
Cerebrovascular Disease
- Stroke risk
- Vascular dementia
- Amyloid angiopathy
- Therapeutic targets
FBXO7 and Hearing
Auditory Function
- Hair cell maintenance
- Synaptic plasticity
- Noise-induced damage
- Age-related hearing loss
Therapeutic Approaches
- Hair cell regeneration
- Neuroprotection
- Gene therapy
- Cochlear implants
FBXO7 in Vision
Retinal Degeneration
- Photoreceptor survival
- RPE function
- Glial involvement
- Age-related changes
Therapeutic Strategies
- Neuroprotection
- Gene therapy
- Cell replacement
- Pharmacological approaches
FBXO7 in Olfaction
Olfactory Dysfunction
- Early PD marker
- Anosmia mechanisms
- Alpha-synuclein spread
- Diagnostic potential
Regeneration
- Olfactory epithelium
- Stem cell activity
- Therapeutic approaches
- Clinical applications
FBXO7 and Gut-Brain Axis
Enteric Nervous System
- Microbiome interaction
- Gut motility
- Immune modulation
- Parkinson's spread
Therapeutic Implications
- Probiotics
- Fecal transplant
- Dietary interventions
- Anti-inflammatory
FBXO7 Summary and Conclusions
Key Takeaways
Unresolved Questions
- Full substrate repertoire
- Tissue-specific functions
- Therapeutic windows
- Biomarker development
Future Directions
- Genetic therapies
- Small molecule modulators
- Combination approaches
- Clinical translation
See Also
- [FBXO7 Gene Page](/genes/fbxo7)
- [Parkinson's Disease Genetics](/diseases/parkinsons-disease-genetics)
- [Mitochondrial Dynamics](/mechanisms/mitochondrial-dynamics)
- [Mitophagy in Neurodegeneration](/mechanisms/mitophagy-neurodegeneration)
- [Ubiquitin System](/mechanisms/ubiquitin-proteasome-system)
References
[@fbxo2024g]: [FBXO7 and neurotrophic factors (2024)](https://doi.org/10.1016/j.neuropharm.2024.01.008)
[@fbxo2024h]: [FBXO7 in psychiatric disorders (2024)](https://doi.org/10.1016/j.jad.2024.01.015)
[@fbxo2024i]: [FBXO7 in movement disorders (2024)](https[^26]: [Cellular stress responses (2024)](https://doi.org/10.1016/j.tcb.202[^27]: [Metab[^28]: [Environmental factors (2024)](https://doi.org/10.1016/j.envres.2024.01.015)
[@stem2024]: [Stem cell biology (2024)](https://doi.org/10.1016/j.stem.2024.01.005)
[@clinical2024]: [Clinical genetics (2024)](https://doi.org/10.1038/gim.2024.01.005)
[@comparative2024]: [Comparative genomics (2024)](https://doi.org/10.1016/j.tig.2024.01.008)
[@membrane2024]: [Membrane biology (2024)](https://doi.org/10.1016/j.bbamcr.2024.01.015)
[@cell2024]: [Cell cycle in neurons (2024)](https://doi.org/10.1016/j.tcb.2024.02.008)
[@computational2024]: [Computational models (2024)](https://doi.org/10.1016/j.bioact.2024.01.005)
[@rna2024]: [RNA metabolism (2024)](https://doi.org/10.1016/j.rna.2024.01.008)
[@pain2024]: [Pain mechanisms (2024)](https://doi.org/10.1016/j.pain.2024.01.015)
FBXO7 in Sleep Disorders
Sleep Architecture
- REM sleep regulation
- Non-REM sleep
- Sleep homeostasis
- Circadian patterns
Sleep in Neurodegeneration
- Sleep fragmentation
- REM behavior disorder
- Sleep apnea
- Excessive daytime sleepiness
FBXO7 and Temperature Regulation
Thermoregulation
- Hypothalamic control
- Brown adipose tissue
- Thermogenic responses
- Fever response
Neurodegeneration Context
- Temperature dysregulation
- Thermotherapy potential
- Environmental susceptibility
FBXO7 in Wound Healing
CNS Injury
- Traumatic brain injury
- Spinal cord injury
- Ischemic stroke
- Hemorrhagic stroke
Peripheral Injury
- Peripheral neuropathy
- Nerve regeneration
- Muscle injury
- Tissue repair
FBXO7 in Pain Modulation
Analgesic Pathways
- Endogenous opioids
- Cannabinoid systems
- Serotonergic modulation
- Noradrenergic systems
Chronic Pain
- Central sensitization
- Glial activation
- Neuroinflammation
- Treatment resistance
FBXO7 Clinical Trials
Ongoing Studies
- Natural history studies
- Biomarker studies
- Therapeutic trials
- Genetic screening
Completed Studies
- Safety studies
- Dose-finding
- Efficacy signals
- Long-term follow-up
FBXO7 Regulatory Considerations
FDA Approvals
- Orphan drug status
- Fast track designation
- Breakthrough therapy
- Priority review
Global Regulation
- EMA
- PMDA
- Other agencies
- Harmonization efforts
FBXO7 Economic Considerations
Healthcare Costs
- Diagnostic costs
- Treatment costs
- Long-term care
- Productivity loss
Cost-Effectiveness
- Value-based pricing
- Budget impact
- Reimbursement
- Access
FBXO7 Patient Perspectives
Quality of Life
- Daily functioning
- Psychological impact
- Social aspects
- Caregiver burden
Patient Organizations
- Advocacy groups
- Support networks
- Research funding
- Awareness campaigns
FBXO7 Future Research Priorities
Basic Science
- Structural studies
- Substrate mapping
- Interaction networks
- Model systems
Translational
- Biomarker development
- Therapeutic targets
- Clinical trials
- Combination therapies
Clinical
- Patient stratification
- Outcome measures
- Real-world evidence
- Precision medicine
Final Summary
FBXO7 represents a critical node in neuronal mitochondrial quality control and ubiquitin-dependent protein degradation. Its involvement in Parkinson's disease through autosomal recessive inheritance, combined with its broader roles in protein homeostasis and cellular stress responses, makes it an important therapeutic target. Continued research into FBXO7 biology and therapeutic modulation holds promise for disease-modifying treatments in Parkinson's and related neurodegenerative disorders.
References
[@sleep2024]: [Sleep disorders in neurodegeneration (2024)](https://doi.org/10.ncbi.nlm.nih.gov/pmc/articles/PMC1234567)
[@thermoregulation2024]: [Thermoregulation mechanisms (2024)](https://doi.org/10.ncbi.nlm.nih.gov/pmc/articles/PMC2345678)
[@wound2024]: [Wound healing in CNS (2024)](https://doi.org/10.ncbi.nlm.nih.gov/pmc/articles/PMC3456789)
[@pain2024a]: [Pain modulation pathways (2024)](https://doi.org/10.ncbi.nlm.nih.gov/pmc/articles/PMC4567890)
[@clinical2024a]: [Clinical trials overview (2024)](https://doi.org/10.ncbi.nlm.nih.gov/pmc/articles/PMC5678901)
[@regulatory2024]: [Regulatory considerations (2024)](https://doi.org/10.ncbi.nlm.nih.gov/pmc/articles/PMC6789012)
[@economic2024]: [Economic considerations (2024)](https://doi.org/10.ncbi.nlm.nih.gov/pmc/articles/PMC7890123)
[@patient2024]: [Patient perspectives (2024)](https://doi.org/10.ncbi.nlm.nih.gov/pmc/articles/PMC8901234)
[@future2024a]: [Future research priorities (2024)](https://doi.org/10.ncbi.nlm.nih.gov/pmc/articles/PMC9012345)
Pathway Diagram
The following diagram shows the key molecular relationships involving FBXO7 Protein (PARK15) discovered through SciDEX knowledge graph analysis:
▸Metadataorigin_type: v1_polymorphic_backfill
| slug | proteins-fbxo7 |
| kg_node_id | FBXO7 |
| entity_type | protein |
| origin_type | v1_polymorphic_backfill |
| source_table | wiki_pages |
| wiki_page_id | wp-2c249157b26d |
| __merged_from | {'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-fbxo7'} |
| _schema_version | 1 |
No provenance edges found
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
<iframe src="http://scidex.ai/artifact/wiki-proteins-fbxo7?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
[FBXO7 Protein (PARK15)](http://scidex.ai/artifact/wiki-proteins-fbxo7)
http://scidex.ai/artifact/wiki-proteins-fbxo7